Publicaciones
El conocimiento generado en IrsiCaixa se comparte con la comunidad científica a través de la publicación de artículos en revistas científicas de alto impacto.
Infection with human retroviruses other than HIV-1: HIV-2, HTLV-1, HTLV-2, HTLV-3 and HTLV-4.
Efficacy of tenofovir and efavirenz in combination with lamivudine or emtricitabine in antiretroviral-naive patients in Europe.
Detection of resistance mutations and CD4 slopes in individuals experiencing sustained virological failure.
An international multicenter study on HIV-1 drug resistance testing by 454 ultra-deep pyrosequencing.
Randomised study to assess the efficacy and safety of once-daily etravirine-based regimen as a switching strategy in HIV-infected patients receiving a protease inhibitor-containing regimen. Etraswitch study.
Patterns of transmitted HIV drug resistance in Europe vary by risk group.
Decreased phenotypic susceptibility to etravirine in patients with predicted genotypic sensitivity.
Genotypic tropism testing in proviral DNA to guide maraviroc initiation in aviremic subjects: 48-week analysis of the PROTEST study.
2014 Update of the drug resistance mutations in HIV-1.
Highly pathogenic adapted HIV-1 strains limit host immunity and dictate rapid disease progression.